In a retrospective study, serum IL-2, IL-4, IL-6, IL-10, IL-17a, TNF-alpha, and IFN-gamma levels were markedly elevated in newly diagnosed MM patients compared to healthy controls; in a multivariate analysis, IL-6 and IL-17a were prognostic factors for survival (72). This evidence concerns the gene IL10 and Miyoshi myopathy.